SWOT Analysis for RPG Life Sciences Ltd.

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years - Nifty500
Relative Outperformance versus Industry over 1 Year
Strong QoQ EPS Growth in recent results
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Company with No Debt
Increasing Revenue every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
Insiders bought stocks

Consistent Highest Return Stocks over Five Years - Nifty500

Relative Outperformance versus Industry over 1 Year

Strong QoQ EPS Growth in recent results

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Company with No Debt

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

Insiders bought stocks

Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Weak Momentum: Price below Short, Medium and Long Term Averages
Increasing Trend in Non-Core Income
RSI indicating price weakness
Top Losers
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Stocks Underperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Weak Momentum: Price below Short, Medium and Long Term Averages

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Promoters increasing shareholding QoQ
Expensive Performers (DVM)
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Promoters increasing shareholding QoQ

Expensive Performers (DVM)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

RPG Life Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

RPG Life Sciences Ltd. has 19 Strengths, 10 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Consistent Highest Return Stocks over Five Years - Nifty500

Relative Outperformance versus Industry over 1 Year

Strong QoQ EPS Growth in recent results

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Company with No Debt

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

Insiders bought stocks

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Weak Momentum: Price below Short, Medium and Long Term Averages

Increasing Trend in Non-Core Income

RSI indicating price weakness

Top Losers

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Promoters increasing shareholding QoQ

Expensive Performers (DVM)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks